a developer of small-molecule drugs addressing major unmet needs in cardiovascular and metabolic diseases
Industry Biotechnology
A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with ETNB. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then ETNB could also see price increases.
Ticker / NAME | Correlation To MDGL | 1D Price Change % | ||
---|---|---|---|---|
MDGL | 100% | -7.05% | ||
ETNB - MDGL | 43% Loosely correlated | -1.49% | ||
MDXG - MDGL | 37% Loosely correlated | +0.13% | ||
AKRO - MDGL | 36% Loosely correlated | -4.35% | ||
CRSP - MDGL | 36% Loosely correlated | -1.85% | ||
BEAM - MDGL | 36% Loosely correlated | -1.57% | ||
More |
Ticker / NAME | Correlation To MDGL | 1D Price Change % |
---|---|---|
MDGL | 100% | -7.05% |
cardiovascular theme (11 stocks) | 96% Closely correlated | +0.87% |
metabolic theme (5 stocks) | 92% Closely correlated | +0.81% |
small molecule theme (11 stocks) | 81% Closely correlated | -1.91% |
pharmaceuticals theme (159 stocks) | 49% Loosely correlated | -1.10% |